To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?

@article{LooNeus2011ToSO,
  title={To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?},
  author={Gigi van de Loo-Neus and Nanda N. J. Rommelse and Jan K. Buitelaar},
  journal={European Neuropsychopharmacology},
  year={2011},
  volume={21},
  pages={584-599}
}
ADHD is a common neuropsychiatric disorder with a strong persistence over time. Medication is frequently used in the clinical management of ADHD. After response, medication is typically prescribed for months to years. It is unclear whether extended medication treatment provides long-term benefits and how long it should be continued. Furthermore, there is concern about the long-term safety of ADHD medication. The aim of this systematic review is to address these issues and provide… Expand
Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms
TLDR
Results from the COMPAS trial demonstrate an improvement of ADHD symptoms over 1.5 years in adults with ADHD after 1 year of treatment with methylphenidate plus either GPT or CM. Expand
Attention deficit hyperactivity disorder in adults
TLDR
Examination of available literature regarding attention deficit hyperactivity disorder in adults found psychological therapy may be beneficial in adults who continue to experience clinically significant symptoms while receiving pharmacotherapy, and these therapies are generally well tolerated. Expand
Effect of Continuing and Discontinuing Medications on Quality of Life After Symptomatic Remission in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis.
TLDR
Discontinuing medications was associated with a small but statistically significant decrease in quality of life among children and adolescents with ADHD but not in adults with ADHD. Expand
Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan
TLDR
It is suggested that IR–MPH is the most frequently prescribed drug for ADHD treatment in Taiwan and an older age at first prescription and a higher daily dose of prescription were significant predictors of early discontinuation of ADHD medication. Expand
Does Long-Term Medication Use Improve the Academic Outcomes of Youth with Attention-Deficit/Hyperactivity Disorder?
TLDR
It is demonstrated that long-term medication use is associated with improvements in standardized achievement scores, however, the magnitude of these improvements is small and the clinical or educational significance is questionable, which highlights methodological considerations in providing directions for future research. Expand
Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial
TLDR
This study will inform mental health care professionals and health insurance companies about the clinical and cost effectiveness of mindfulness training for children and adolescents with ADHD and their parents compared to the effectiveness of methylphenidate. Expand
Effect of Treatment Modality on Long-Term Outcomes in Attention-Deficit/Hyperactivity Disorder: A Systematic Review
TLDR
The combination of pharmacological and non-pharmacological treatment was most consistently associated with improved long-term outcomes and large effect sizes. Expand
Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and Atomoxetine.
TLDR
It is suggested that discontinuing a drug during the holiday period may be popular for people undergoing ADHD pharmacotherapy, especially with regard to methylphenidate prescriptions. Expand
First-Time Users of ADHD Medication Among Children and Adolescents in Germany: An Evaluation of Adherence to Prescribing Guidelines Based on Claims Data
TLDR
The results suggest the need for improvement in rational prescribing, especially with regard to diagnostic requirements, in first-time users of ADHD medication among children and adolescents in Germany. Expand
Slow cortical potential neurofeedback and self-management training in outpatient care for children with ADHD: study protocol and first preliminary results of a randomized controlled trial
TLDR
First preliminary results show positive effects, and this is the first randomized controlled trial to test the effectiveness of a NF protocol in a high frequent outpatient care setting that does not exclude children on or with changes in medication. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 122 REFERENCES
Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths.
  • S. Faraone
  • Medicine
  • P & T : a peer-reviewed journal for formulary management
  • 2009
TLDR
Although nearly all of the ADHD medications had significant effects, there was substantial variability and when translated into the costs of treating large numbers of patients, these effect sizes have implications for formulary medication choices. Expand
Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.
TLDR
In patients who responded favorably to 12 weeks of initial treatment, atomoxetine was superior to placebo in maintaining response for the ensuing 9 months, and this result supports the value of maintenance treatment with atomxetine in patients with ADHD who respond to initial treatment. Expand
Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.
TLDR
The results of this long-term, placebo-controlled study of the central stimulant amphetamine in the treatment of ADHD indicate that there are remaining positive effects of the drug 15 months after starting treatment. Expand
A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
TLDR
Although both stimulant and nonstimulant medications are effective for treating ADHD in adults, stimulant medications show greater efficacy for the short durations of treatment characteristic of placebo-controlled studies. Expand
Childhood hyperactivity and psychostimulants: a review of extended treatment studies.
TLDR
Evidence from the more definitive randomized controlled trials indicates that stimulants are more effective in ameliorating the core behavioral symptoms of ADHD than placebos, nonpharmacological therapies, or no treatment-at least in 3-7-month trials. Expand
Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
TLDR
Long-term treatment with methylphenidate seems to be safe and effective for the management of ADHD behaviors in many (but not necessarily all) children with mild to moderate tic disorder. Expand
A Randomized, Double-Blind Study of Continuation Treatment for Attention-Deficit/Hyperactivity Disorder After 1 Year
TLDR
There was considerable variability between individuals in the magnitude of symptom return after drug discontinuation, suggesting that some subjects treated with atomoxetine for a year with good results may consolidate gains made during drug treatment and could benefit from a medication-free trial to assess the need for ongoing drug treatment. Expand
Long-Term Stimulant Medication Treatment of Attention-Deficit/Hyperactivity Disorder: Results from a Population-Based Study
TLDR
It is demonstrated that the effectiveness of stimulant medication treatment of ADHD provided throughout childhood is comparable to the efficacy of Stimulant treatment demonstrated in clinical trials. Expand
Treatment of ADHD in children with tics: a randomized controlled trial.
TLDR
Methylphenidate and clonidine (particularly in combination) are effective for ADHD in children with comorbid tics, and prior recommendations to avoid methylphenidate in these children because of concerns of worsening tics are unsupported by this trial. Expand
Treatment of ADHD in children with tics: A randomized controlled trial
TLDR
Methylphenidate and clonidine (particularly in combination) are effective for ADHD in children with comorbid tics, and prior recommendations to avoid methylphenidate in these children because of concerns of worsening tics are unsupported by this trial. Expand
...
1
2
3
4
5
...